AbbVie Inc. (ABBV) stock
ABBVNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 10/3090% above fair value
$292.82−1.73 (-0.59%)
Close on Nov 17, 2026Market cap $517.45BP/E 82.7Yield 2.27%
AbbVie market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
AbbVie's market cap was $523.07B on Nov 11, 2026, against $403.66B a year earlier. Over the last 5 years it ranged from $238.59B to $523.07B, with a median of $315.06B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $523.07B | +29.1% |
| 2025 | Dec 31, 2025 | $405.06B | +28.6% |
| 2024 | Dec 31, 2024 | $315.06B | +14.6% |
| 2023 | Dec 29, 2023 | $275.03B | -4.3% |
| 2022 | Dec 30, 2022 | $287.26B | +19.4% |
| 2021 | Dec 31, 2021 | $240.64B | +40.5% |
| 2020 | Dec 31, 2020 | $171.23B | +30.0% |
| 2019 | Dec 31, 2019 | $131.73B | -9.1% |
| 2018 | Dec 31, 2018 | $144.95B | -6.8% |
| 2017 | Dec 29, 2017 | $155.49B | +51.9% |
| 2016 | Dec 30, 2016 | $102.38B | +6.1% |
| 2015 | Dec 31, 2015 | $96.53B | -8.3% |
| 2014 | Dec 31, 2014 | $105.31B | +24.7% |
| 2013 | Dec 31, 2013 | $84.44B | – |
See a number that looks wrong?